Many commercial cannabis cultivators invest millions in state-of-the-art greenhouses, high-tech lighting, and premium genetics—only to hit a brick wall when trying to execute a Medical Cannabis export contract.
Why does this happen? Because high quality in the greenhouse does not automatically equal compliance in foreign markets.
The Problem: The “Certification Gap”
Overseas pharmaceutical buyers operate under ultra-strict healthcare regulations. They cannot risk importing raw cannabis flower that lacks verifiable quality assurance documentation. Without standardized proof of safety, even the highest-grade cannabis will be turned away at customs.
The Solution: Standardizing Cultivation via GACP
The fastest way to close this gap is by achieving Good Agricultural and Collection Practices (GACP) compliance. GACP eliminates risks by enforcing strict controls over:
- Preventative contamination measures during growth and harvest.
- Standardized post-harvest drying and curing to lock in cannabinoid profiles.
- Complete batch documentation ensuring 100% supply chain transparency.
Taking Action Toward Compliance
Achieving certification requires a clear understanding of what international auditors look for during an evaluation. Resources like the SGS GACP for Medical Cannabis Export Market educational guide offer growers practical insights into compliance requirements, helping turn export ambitions into active international revenue.